Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
Lab-Confirmed HIV Rate 33% Among Kenyans With Prior Tuberculosis

Among Kenyans with prior tuberculosis, one third had lab-confirmed HIV infection, according to results of a nationally representative survey. Adult HIV prevalence stood at 5.6%.

Published
07 May 2014
From
International AIDS Society
Otsuka Wins European Marketing Authorization for Deltyba™ (delamanid)

First grant of a marketing authorization of Otsuka’s novel drug for multidrug-resistant tuberculosis (MDR-TB).

Published
01 May 2014
From
Otsuka press release
Antibiotic crisis bigger than Aids as common infections will kill, WHO warns

The report, Antimicrobial resistance: global report on surveillance focuses on antibiotic resistance in seven different bacteria responsible for common, serious diseases such as sepsis, diarrhoea, pneumonia, urinary tract infections and gonorrhoea.It found that antibiotic resistance is present in all areas of the globe and is growing.

Published
30 April 2014
From
Daily Telegraph
CROI 2014: Chronic lung disease is prevalent and under-diagnosed in people with HIV

Even though the incidence of most HIV-related respiratory complications and opportunistic infections have declined dramatically since the advent of effective antiretroviral therapy (ART), 4 studies presented at the 21st Conference on Retroviruses and Opportunistic Infections (CROI) last month in Boston showed that people living with HIV are still at increased risk...

Published
28 April 2014
From
HIVandHepatitis.com
New and better drugs for MDR-TB on the horizon

A phase III trial of a novel combination of drugs for tuberculosis, including some drug-resistant strains, will launch within the year, the TB Alliance announced.

Published
24 April 2014
From
The Guardian
South Africa: ARV Programme Saves 780 000 Lives

South Africa's HIV antiretroviral treatment programme saved 780 000 lives between 2003 and 2012, according to a recently released independent review. But the tuberculosis programme is failing to meet targets.

Published
14 April 2014
From
Health-e
Big Pharma Abandons New Tuberculosis Drug Research

Three major pharmaceutical companies - AstraZeneca, Johnson & Johnson and Pfizer - have recently delayed or canceled clinical trials for testing tuberculosis (TB) drugs in India and South Africa. Activists say this is symbolic of a trend by Big Pharma to abandon research into diseases that affect poor people.

Published
02 April 2014
From
CorpWatch.org
Mass TB Tests 'Would Save Billions'

A World Bank study has estimated that South Africa, Lesotho, Swaziland, and Mozambique could save approximately 13 billion rand a year in increased productivity and reduced TB transmission by spending 330 million rand per year to test and treat miners in the gold and platinum mining industry for TB.

Published
31 March 2014
From
Business Daily
Announcement: Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis

The updated guidelines include recommendations for use of newer antiretroviral drugs, including those in new classes, such as CCR5 receptor antagonists and integrase inhibitors. The new guidelines provide additional recommendations regarding use of rifampin with antiretroviral therapy; these recommendations are critical in regions where rifabutin is unavailable.

Published
31 March 2014
From
Morbidity and Mortality Weekly Report
New consensus reached to help tackle multidrug-resistant and extensively drug-resistant TB

New consensus statements have been developed to help tackle the growing threat of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.

Published
26 March 2014
From
Eurekalert Medicine & Health

Filter by country